BROSSARD, QUEBEC--(Marketwire - Dec. 6, 2012) - DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in the use of artificial intelligence and advanced knowledge extraction techniques, announces today an update on the extension of 15 months to the term for exercise of the eligible warrants issued as part of the most recent private placement announced on May 26, 2011.
In addition to what was announced on November 21, 2012, the number of warrants eligible to the extended term of 15 months totals 5,545,173 of which 73.83% is held by insiders of the Corporation.
The amendment to warrant term is currently under review by the TSX Venture.
Founded in 1998, DIAGNOS is a publicly traded Canadian corporation (TSX VENTURE:ADK), with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including healthcare and natural resources.
For further information, please visit our website at www.diagnos.com or the SEDAR website at www.sedar.com.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Andre Larente, President
Bid Capital Markets